Please login to the form below

Not currently logged in
Email:
Password:

Road wins Helperby Therapeutics account

Agency will provide communications support to the antibiotics firmN

ROADLondon-based healthcare comms agency Road has been appointed by Helperby Therapeutics to provide communications around its work on antimicrobial resistance.

Road will be launching offline, digital and social media programmes to engage the medical and investment communities in conversations around antibiotics and resistance.

Helperyby is working on antiobiotic technology that it hopes will battle microbial resistance by combining new resistance breakers with existing antibiotics to create a “new generation of therapies”.

Frances Crewsdon, chief operating officer at Helperby, said: “There has been no new class of antibiotic produced over thirty years.

“This new lease of life for antibiotics has the potential to help sustain our defence against life threatening superbugs for years to come.”

The threat of antimicrobial resistance continues to attract a high-level response, most recently with the EU bringing together stakeholders across Europe last month to define common policies to fight AMR and control hospital-acquired infections.

Article by
Gemma Jones

2nd October 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics